Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smoking cessation aid coverage by Medicaid, private insurers urged by AMA delegates.

This article was originally published in The Tan Sheet

Executive Summary

FDA-APPROVED SMOKING CESSATION "PHARMACOTHERAPY" COVERAGE by Medicaid and private sector insurers is recommended in a resolution passed by the American Medical Association House of Delegates June 17 during AMA's annual meeting in Chicago. The phrase "FDA-approved pharmacotherapy" is a compromise between supporters of the original language of a committee resolution dealing with smoking cessation, which refers to "prescription medications," and some delegates who would have preferred the resolution to explicitly include OTC therapies as well.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts